Bill Sponsor
House Bill 4393
116th Congress(2019-2020)
Advancing Access to Precision Medicine Act
Introduced
Introduced
Introduced in House on Sep 18, 2019
Overview
Text
Introduced
Sep 18, 2019
Latest Action
Sep 19, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4393
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
California
Republican
Alabama
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
District of Columbia
Democrat
Illinois
Democrat
Maryland
Democrat
Maryland
Democrat
Massachusetts
Democrat
New York
Democrat
North Carolina
Republican
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Republican
Tennessee
Democrat
Virginia
Democrat
Wisconsin
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Advancing Access to Precision Medicine Act

This bill allows state Medicaid programs to cover DNA sequencing clinical services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to a pediatric intensive care unit and seen by a medical specialist for a chronic or undiagnosed disease, and (2) are suspected by a medical specialist to have a pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Additionally, the National Academy of Medicine must study the effects of genetic and genomic testing and ways to expand health insurance coverage of such services, including under Medicare and Medicaid.

Text (1)
September 18, 2019
Actions (3)
09/19/2019
Referred to the Subcommittee on Health.
09/18/2019
Referred to the House Committee on Energy and Commerce.
09/18/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:58 PM